PERSONALIS INC (PSNL) Fundamental Analysis & Valuation

NASDAQ:PSNL • US71535D1063

Current stock price

6.24 USD
-0.1 (-1.58%)
At close:
6.34 USD
+0.1 (+1.6%)
Pre-Market:

This PSNL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PSNL Profitability Analysis

1.1 Basic Checks

  • PSNL had negative earnings in the past year.
  • In the past year PSNL has reported a negative cash flow from operations.
  • In the past 5 years PSNL always reported negative net income.
  • In the past 5 years PSNL always reported negative operating cash flow.
PSNL Yearly Net Income VS EBIT VS OCF VS FCFPSNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -24.32%, PSNL is not doing good in the industry: 69.64% of the companies in the same industry are doing better.
  • The Return On Equity of PSNL (-31.12%) is worse than 60.71% of its industry peers.
Industry RankSector Rank
ROA -24.32%
ROE -31.12%
ROIC N/A
ROA(3y)-34.17%
ROA(5y)-31.53%
ROE(3y)-51.61%
ROE(5y)-45.56%
ROIC(3y)N/A
ROIC(5y)N/A
PSNL Yearly ROA, ROE, ROICPSNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • PSNL has a worse Gross Margin (22.65%) than 82.14% of its industry peers.
  • PSNL's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PSNL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.35%
GM growth 5Y-2.39%
PSNL Yearly Profit, Operating, Gross MarginsPSNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PSNL Health Analysis

2.1 Basic Checks

  • PSNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PSNL has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PSNL has been increased compared to 5 years ago.
  • The debt/assets ratio for PSNL is higher compared to a year ago.
PSNL Yearly Shares OutstandingPSNL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
PSNL Yearly Total Debt VS Total AssetsPSNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 2.88 indicates that PSNL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • PSNL's Altman-Z score of 2.88 is fine compared to the rest of the industry. PSNL outperforms 66.07% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that PSNL is not too dependend on debt financing.
  • PSNL's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. PSNL outperforms 69.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.88
ROIC/WACCN/A
WACC10.98%
PSNL Yearly LT Debt VS Equity VS FCFPSNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • PSNL has a Current Ratio of 6.76. This indicates that PSNL is financially healthy and has no problem in meeting its short term obligations.
  • PSNL has a better Current ratio (6.76) than 89.29% of its industry peers.
  • PSNL has a Quick Ratio of 6.61. This indicates that PSNL is financially healthy and has no problem in meeting its short term obligations.
  • PSNL's Quick ratio of 6.61 is amongst the best of the industry. PSNL outperforms 89.29% of its industry peers.
Industry RankSector Rank
Current Ratio 6.76
Quick Ratio 6.61
PSNL Yearly Current Assets VS Current LiabilitesPSNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PSNL Growth Analysis

3.1 Past

  • PSNL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.58%, which is quite impressive.
  • PSNL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.69%.
  • Measured over the past years, PSNL shows a decrease in Revenue. The Revenue has been decreasing by -2.40% on average per year.
EPS 1Y (TTM)33.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-17.69%
Revenue growth 3Y2.3%
Revenue growth 5Y-2.4%
Sales Q2Q%3.24%

3.2 Future

  • Based on estimates for the next years, PSNL will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.61% on average per year.
  • PSNL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.14% yearly.
EPS Next Y-16.25%
EPS Next 2Y-0.11%
EPS Next 3Y11.43%
EPS Next 5Y14.61%
Revenue Next Year12.94%
Revenue Next 2Y25.4%
Revenue Next 3Y31.48%
Revenue Next 5Y26.14%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PSNL Yearly Revenue VS EstimatesPSNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
PSNL Yearly EPS VS EstimatesPSNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. PSNL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PSNL. In the last year negative earnings were reported.
  • Also next year PSNL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNL Price Earnings VS Forward Price EarningsPSNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNL Per share dataPSNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.11%
EPS Next 3Y11.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PSNL Dividend Analysis

5.1 Amount

  • No dividends for PSNL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PSNL Fundamentals: All Metrics, Ratios and Statistics

PERSONALIS INC

NASDAQ:PSNL (3/30/2026, 8:25:39 PM)

Premarket: 6.34 +0.1 (+1.6%)

6.24

-0.1 (-1.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners63.34%
Inst Owner Change12.74%
Ins Owners0.97%
Ins Owner Change1.15%
Market Cap652.89M
Revenue(TTM)69.65M
Net Income(TTM)-81.27M
Analysts83.08
Price Target11.66 (86.86%)
Short Float %15.01%
Short Ratio7.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.3%
Min EPS beat(2)13.04%
Max EPS beat(2)15.55%
EPS beat(4)4
Avg EPS beat(4)16.17%
Min EPS beat(4)7.49%
Max EPS beat(4)28.59%
EPS beat(8)7
Avg EPS beat(8)10.07%
EPS beat(12)9
Avg EPS beat(12)7.53%
EPS beat(16)11
Avg EPS beat(16)6.23%
Revenue beat(2)1
Avg Revenue beat(2)2.3%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)6.79%
Revenue beat(4)2
Avg Revenue beat(4)1.11%
Min Revenue beat(4)-16.15%
Max Revenue beat(4)15.99%
Revenue beat(8)6
Avg Revenue beat(8)5.81%
Revenue beat(12)8
Avg Revenue beat(12)4.62%
Revenue beat(16)12
Avg Revenue beat(16)5.49%
PT rev (1m)2.56%
PT rev (3m)3.9%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)1.65%
EPS NY rev (1m)-6.14%
EPS NY rev (3m)-6.92%
Revenue NQ rev (1m)-18.87%
Revenue NQ rev (3m)-22.24%
Revenue NY rev (1m)-3.37%
Revenue NY rev (3m)-6.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.37
P/FCF N/A
P/OCF N/A
P/B 2.5
P/tB 2.5
EV/EBITDA N/A
EPS(TTM)-0.91
EYN/A
EPS(NY)-1.06
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS0.67
BVpS2.5
TBVpS2.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.32%
ROE -31.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.65%
FCFM N/A
ROA(3y)-34.17%
ROA(5y)-31.53%
ROE(3y)-51.61%
ROE(5y)-45.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.35%
GM growth 5Y-2.39%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.83%
Cap/Sales 6.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.76
Quick Ratio 6.61
Altman-Z 2.88
F-Score3
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)52.03%
Cap/Depr(5y)186.47%
Cap/Sales(3y)7.74%
Cap/Sales(5y)22.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
EPS Next Y-16.25%
EPS Next 2Y-0.11%
EPS Next 3Y11.43%
EPS Next 5Y14.61%
Revenue 1Y (TTM)-17.69%
Revenue growth 3Y2.3%
Revenue growth 5Y-2.4%
Sales Q2Q%3.24%
Revenue Next Year12.94%
Revenue Next 2Y25.4%
Revenue Next 3Y31.48%
Revenue Next 5Y26.14%
EBIT growth 1Y-28.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.3%
EBIT Next 3Y16.39%
EBIT Next 5Y18.11%
FCF growth 1Y-69.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.99%
OCF growth 3YN/A
OCF growth 5YN/A

PERSONALIS INC / PSNL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PERSONALIS INC?

ChartMill assigns a fundamental rating of 2 / 10 to PSNL.


Can you provide the valuation status for PERSONALIS INC?

ChartMill assigns a valuation rating of 0 / 10 to PERSONALIS INC (PSNL). This can be considered as Overvalued.


What is the profitability of PSNL stock?

PERSONALIS INC (PSNL) has a profitability rating of 0 / 10.


What is the financial health of PERSONALIS INC (PSNL) stock?

The financial health rating of PERSONALIS INC (PSNL) is 5 / 10.